Thyrocare Technologies jumps on making additional equity investment in Thyrocare Laboratories (Tanzania)
Thyrocare Technologies is currently trading at Rs. 680.65, up by 18.40 points or 2.78% from its previous closing of Rs. 662.25 on the BSE.
The scrip opened at Rs. 670.00 and has touched a high and low of Rs. 685.90 and Rs. 658.00 respectively. So far 3174 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1053.05 on 06-Jan-2025 and a 52 week low of Rs. 555.85 on 27-Mar-2024.
Last one week high and low of the scrip stood at Rs. 738.95 and Rs. 658.00 respectively. The current market cap of the company is Rs. 3607.00 crore.
The promoters holding in the company stood at 71.06%, while Institutions and Non-Institutions held 17.44% and 11.50% respectively.
Thyrocare Technologies has made an additional equity investment of $25,000 (equivalent to Rs 21.98 lakh) in Thyrocare Laboratories (Tanzania) (the 'JV company'). Upon the allotment of shares by the JV company, the JV company will become a subsidiary of the Company. The JV company is engaged in providing diagnostic and healthcare services directly to customers in the United Republic of Tanzania.
The equity infusion in the JV company has been made to facilitate its business operations and working capital requirements. The JV company's business is similar to the company’s main line of business viz. diagnostic and healthcare services.
Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in several cities / towns in India and internationally.
